Uganda Cancer Institute

Kampala PO Box 3935

1 studies enrolling now · 8 studies all time

What they study most

Breast Cancer, Early Breast Cancer, Hepatocellular Carcinoma, Locally Advanced or Metastatic Breast Cancer, Lymphoma, Metastatic Breast Cancer, Recurrent Kaposi Sarcoma, Sickle Cell Disease, Skin Kaposi Sarcoma

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer) — Running, not enrolling
• A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) — Running, not enrolling
• A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy — Running, not enrolling
• A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152) — Running, not enrolling
• Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma — Completed
• A Study of IMR-687 in Subjects With Sickle Cell Disease — Stopped early
• Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma — Completed